Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations

被引:14
作者
Belge, G
Rippe, V
Meiboom, M
Drieschner, N
Garcia, E
Bullerdiek, J
机构
[1] Univ Bremen, Ctr Human Genet & Genet Counseling, Bremen, Germany
[2] Lawrence Livermore Natl Lab, Livermore, CA USA
来源
CYTOGENETICS AND CELL GENETICS | 2001年 / 93卷 / 1-2期
关键词
D O I
10.1159/000056947
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Structural rearrangements involving the long arm of chromosome 19 characterize a cytogenetic subgroup of benign thyroid tumors and constitute one of the most frequent specific chromosome abnormalities in epithelial tumors. Recently. we have been able to narrow down the breakpoint region affected in two cell lines to a region covered by a single PAC clone. Close to that region a candidate gene has been identified which we tentatively referred to as RITA (Rearranged In Thyroid Adenomas) now named ZNF331 according to HUGO nomenclature. However, the results had been obtained on two cell lines only making it necessary to extend the studies to a larger number of tumors including primary material. Herein, we have used four further primary tumors showing translocations involving 19q13 for fluorescence in situ hybridization (FISH) mapping studies using a variety of molecular probes from a 470-kbp cosmid/BAC contig. Ten new STSs were characterized and physically mapped within an EcoRI restriction map. The results enabled us to define an approximately 150-kbp breakpoint cluster region of the 19q13 aberrations in benign thyroid tumors flanked by two newly established STS markers. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:48 / 51
页数:4
相关论文
共 19 条
[1]   AN INTEGRATED METRIC PHYSICAL MAP OF HUMAN-CHROMOSOME-19 [J].
ASHWORTH, LK ;
BATZER, MA ;
BRANDRIFF, B ;
BRANSCOMB, E ;
DEJONG, P ;
GARCIA, E ;
GARNES, JA ;
GORDON, LA ;
LAMERDIN, JE ;
LENNON, G ;
MOHRENWEISER, H ;
OLSEN, AS ;
SLEZAK, T ;
CARRANO, AV .
NATURE GENETICS, 1995, 11 (04) :422-427
[2]   CYTOGENETIC FINDINGS ON 8 FOLLICULAR THYROID ADENOMAS INCLUDING ONE WITH A T(10-19) [J].
BARTNITZKE, S ;
HERRMANN, ME ;
LOBECK, H ;
ZUSCHNEID, W ;
NEUHAUS, P ;
BULLERDIEK, J .
CANCER GENETICS AND CYTOGENETICS, 1989, 39 (01) :65-68
[3]   EXPRESSION OF SV40 T-ANTIGEN IN LIPOMA CELLS WITH A CHROMOSOMAL TRANSLOCATION T(3-12) IS NOT SUFFICIENT FOR DIRECT IMMORTALIZATION [J].
BELGE, G ;
KAZMIERCZAK, B ;
MEYERBOLTE, K ;
BARTNITZKE, S ;
BULLERDIEK, J .
CELL BIOLOGY INTERNATIONAL REPORTS, 1992, 16 (04) :339-347
[4]   Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology [J].
Belge, G ;
Rogue, L ;
Soares, J ;
Bruckmann, S ;
Thode, B ;
Fonseca, E ;
Clode, A ;
Bartnitzke, S ;
Castedo, S ;
Bullerdiek, J .
CANCER GENETICS AND CYTOGENETICS, 1998, 101 (01) :42-48
[5]  
BELGE G, 1995, CYTOGENET CELL GENET, V69, P220
[6]  
Belge G, 1997, GENE CHROMOSOME CANC, V20, P201, DOI 10.1002/(SICI)1098-2264(199710)20:2<201::AID-GCC11>3.0.CO
[7]  
2-T
[8]   ABERRATIONS OF CHROMOSOME-8 IN MIXED SALIVARY-GLAND TUMORS - CYTOGENETIC FINDINGS ON 7 CASES [J].
BULLERDIEK, J ;
BOSCHEN, C ;
BARTNITZKE, S .
CANCER GENETICS AND CYTOGENETICS, 1987, 24 (02) :205-212
[9]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[10]  
DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985